🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
KNS
$KNSA
🔒 US EquitiesKiniksa Pharmaceuticals Ltd
AVG HISTORICAL GAP
+2.65%
MAX GAP RECORD
-22.73%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $KNSA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$KNSA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 27, 2026 Earnings Release 2026-10-27 (BEFORE OPEN (08:00)) |
+16.47%
|
| Jul 28, 2026 Earnings Release 2026-07-28 (BEFORE OPEN) |
+10.27%
|
| Apr 28, 2026 Earnings Release 2026-04-28 (BEFORE OPEN) |
+8.23%
|
| Feb 24, 2026 Earnings Release 2026-02-24 (BEFORE OPEN) |
-9.79%
|
| Oct 28, 2025 Earnings Release 2025-10-28 (BEFORE OPEN) |
+1.88%
|
| Jul 29, 2025 Earnings Release 2025-07-29 (BEFORE OPEN) |
+13.17%
|
| Apr 29, 2025 Earnings Release 2025-04-29 (BEFORE OPEN) |
+5.03%
|
| Feb 25, 2025 Earnings Release 2025-02-25 (BEFORE OPEN) |
-2.19%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
7.6%
Bullish Gaps (9)
Bearish Gaps (4)
Neutral / Flat (3)
📖 Intelligence Summary
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗